Therapeutic benefits of Ipilimumab among Japanese patients with Nivolumab-refractory mucosal melanoma: A case series study

Ken Saijo, Hiroo Imai, Kota Ouchi, Yoshinari Okada, Yuko Sato, Keigo Komine, Masahiro Takahashi, Shin Takahashi, Hidekazu Shirota, Masanobu Takahashi, Chikashi Ishioka

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Therapeutic benefits of Ipilimumab among Japanese patients with Nivolumab-refractory mucosal melanoma: A case series study'. Together they form a unique fingerprint.

Medicine and Dentistry

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Neuroscience